Next-Generation-Sequencing for Non-Invasive Prenatal Testing (NGS-NIPT) in China

The Market for Next-Generation-Sequencing Neonatal Testing (NGS-NIPT) in China

Next Generation NIPT Sequencing in China estimates the revenues for non-invasive prenatal testing in this emerging market, and generally analyzes the role of next generation sequencing (NGS) in the country. Estimates in this report include revenues for non-invasive prenatal testing using sequencing in China, projections to 2020, market share. Institutions performing NGS and key equipment manufacturers and service providers are discussed.

This report was created as a cooperative project between Kalorama Information and The Freedonia Group, with staff from Freedonia’s Beijing office completing primary and secondary research.

  • Executive Summary
    • Scope and Methodology
    • Major Findings of The Report
  • Introduction
    • China in Perspective
      • Table Provinces of China
    • Population Trends and Demographics
      • Aging of Population
    • Growing Chinese Hospital Sector
      • Number of Hospitals in China, 2004 2015
        • Table Hospitals in China 2004-2015
      • Hospitals in China by Class (Class I, Class II, Class III)
        • Table Hospitals in China by Type (Class I, Class II, Class III)
      • Resource Constraints in Hospitals
    • Intellectual Property Issues
    • Higher Out of Pocket Spending in China
      • Percent of Spending Out of Pocket: China vs. Other Nations
        • Table Percent of Healthcare Spending Out of Pocket
    • Healthcare Reform
    • Disease Costs
    • Sequencing Introduction
      • Sanger
      • Next Generation Sequencing
      • Sequencing in China
      • Products Approved
        • Table Next Generation Sequencing Products Approved in China
      • Institutions Performing NGS in China
        • Table Chinese Institutions Approved for Next Generation Sequencing.
    • Technologies Used for Newborn Screening
      • Traditional Tests
      • Sequencing
  • Market Analysis
    • Introduction
      • Relevant Demographics
        • Table Relevant Demographics
    • Hospital Use of NGS
      • Hospitals Using NGS: Outsourced vs. In House
        • Table Penetration of NGS – NIPT in China Hospital
    • Major Competitors
      • Leading Companies in Next Generation Sequencing in China (Equipment Providers, TestMakers, Service Providers)
        • Table Leading Companies in Next Generation Sequencing in China
    • Chinese NGS NIPT Market
      • Market Size and Forecast to 2020
        • Table NGS NIPT Market in China
      • Market Share of NGS NIPT in China and Competitive Analysis
        • Table Market Share in Next Generation Sequencing in China
      • Emerging NGS Applications in China
  • NGS Competitors in China
    • Annoroad
    • Amoy Diagnostics Co., LTD
    • Berry Genomics Co. Ltd
    • Beijing Genomics Institute (BGI)
    • CapitalBio Corporation
    • Novogene
    • Daan Gene Co., Ltd.
    • Shanghai Kehua Bio engineering
    • Zhejiang Dian Diagnostics
    • Wuxi AppTec Co. LTD.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings